H. Bauer, . Fritz-wolf-k, . Winzer-a, S. Kuhner, S. Little et al., A fluoro analogue of the menadione deriva-NOVEL TARGETS FOR ANTIMALARIAL CHEMOTHERAPY

, -methyl)-1',4'-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme, J. Am. Chem. Soc, vol.128, pp.10784-10794, 2006.

. Benoit-vical-f, J. Lelievre, . Berry-a, C. Deymier, . Dechy-cabaret-o et al.,

&. Meunier and B. , Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother, vol.51, pp.1463-1472, 2007.

. Chakrabarti-d, S. T. Da, J. Barger, . Paquette-s, H. Patel et al., Protein farnesyltransferase and protein prenylation in Plasmodium falciparum, J. Biol. Chem, vol.277, pp.42066-42073, 2002.

C. Doerig and . Meijer-l, Antimalarial drug discovery: targeting protein kinases, Expert. Opin. Ther. Targets, vol.11, pp.279-290, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00169407

. T. Eastman-r, J. White, O. Hucke, . Bauer-k, K. Yokoyama et al., Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum, J. Biol. Chem, vol.280, pp.13554-13559, 2005.

. T. Eastman-r, J. White, O. Hucke, K. Yokoyama, C. L. Verlinde et al., Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase, Mol. Biochem. Parasitol, vol.152, pp.66-71, 2007.

. Eckstein-ludwig-u, . J. Webb-r, . D. Van-goethem-i, J. M. East, . G. Lee-a et al., Artemisinins target the SERCA of Plasmodium falciparum, Nature, vol.424, pp.957-961, 2003.

M. Flipo, T. Beghyn, . Leroux-v, . Florent-i, . P. Deprez-b et al., Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents, J. Med. Chem, vol.50, pp.1322-1334, 2007.

. J. Foth-b, . A. Ralph-s, C. J. Tonkin, . S. Struck-n, M. Fraunholz et al., Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum, Science, vol.299, pp.705-708, 2003.

J. S. Freundlich, . Wang-f, H. C. Tsai, M. Kuo, H. M. Shieh et al., X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy, J. Biol. Chem, vol.282, pp.25436-25444, 2007.

. H. Gelb-m, . C. Van-voorhis-w, . S. Buckner-f, K. Yokoyama, . Eastman-r et al., Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics, Mol. Biochem. Parasitol, vol.126, pp.155-163, 2003.

. E. Goldberg-d, Hemoglobin degradation, Curr. Top. Microbiol. Immunol, vol.295, pp.275-291, 2005.

J. Golenser, J. H. Waknine, M. Krugliak, . H. Hunt-n, and . E. Grau-g, Current perspectives on the mechanism of action of artemisinins, Int. J. Parasitol, vol.36, pp.1427-1441, 2006.

. D. Goodman-c, . &. Su-v, and . Mcfadden-g.i, The effects of antibacterials on the malaria parasite Plasmodium falciparum, Mol. Biochem. Parasitol, vol.152, pp.181-191, 2007.

J. E. Hyde, Targeting purine and pyrimidine metabolism in human apicomplexan parasites, Curr. Drug Targets, vol.8, pp.31-47, 2007.

. Jambou-r, E. Legrand, M. Niang, N. Khim, . Lim-p et al., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6, vol.366, pp.1960-1963, 2005.

J. M. Kim, H. , and N. K. No-k, Three-dimensional structure of Plasmodium falciparum Ca 2+ -ATPase(PfATP6) and docking of artemisinin derivatives to PfATP6, Bioorg. Med. Chem. Lett, vol.15, pp.2994-2997, 2005.

K. S. Woodrow-c, H. M. Staines, . K. Haynes-r, and . Mer-cereau-puijalon-o, Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance, Trends Mol. Med, vol.12, pp.200-205, 2006.

M. Labaied, . Dagan-a, M. Dellinger, M. Geze, S. Egee et al., Anti-Plasmodium activity of ceramide analogs, Malar. J, p.49, 2004.
URL : https://hal.archives-ouvertes.fr/mnhn-02070122

. Lell-b.-&-kremsner-p.g, Clindamycin as an antimalarial drug: review of clinical trials, Antimicrob. Agents Chemother, vol.46, pp.2315-2320, 2002.

. Lell-b, . Ruangweerayut-r, J. Wiesner, M. A. Missinou, . Schind-ler-a et al., Fosmidomycin, a novel chemotherapeutic agent for malaria, Antimicrob. Agents Chemother, vol.47, pp.735-738, 2003.

. Mambu-l.-&-grellier-p, Antimalarial compounds from traditionally-used medicinal plants, in: Bioactive natural products. Detection, isolation and structural determination, pp.491-529, 2007.

. W. Mather-m, . W. Henry-k, and . B. Vaidya-a, Mitochondrial drug targets in apicomplexan parasites, Curr. Drug Targets, vol.8, pp.49-60, 2007.

M. J. Striepen-b, Make it or take it: fatty acid metabolism of apicomplexan parasites, Eukaryot. Cell, vol.6, pp.1727-1735, 2007.

. Mcrobert-l, . Jiang-s, . Stead-a, and . A. Mcconkey-g, Plasmodium falciparum: interaction of shikimate analogues with antimalarial drugs, Exp. Parasitol, vol.111, pp.178-181, 2005.

M. D. Matsika-claquin-m, D. Djalle, F. Yapou, . Mani-rakiza-a, V. Dolmazon et al., Association of failures of seven-day courses of artesunate in a nonimmune population in Bangui, Central African Republic with decreased sensitivity of Plasmodium falciparum, Am J. Trop. Med. Hyg, vol.73, pp.616-621, 2005.

. Nagamune-k and . D. Sibley-l, Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa, Mol. Biol. Evol, vol.23, pp.1613-1627, 2006.

. Nallan-l, . D. Bauer-k, P. Bendale, . Rivas-k, K. Yokoyama et al., Protein farnesyltransferase inhibitors exhibit potent antimalarial activity, J. Med. Chem, vol.48, pp.3704-3713, 2005.

. A. O'donnell-r and . J. Blackman-m, The role of malaria merozoite proteases in red blood cell invasion, Curr. Opin. Microbiol, vol.8, pp.422-427, 2005.

J. Ohkanda, J. W. Lockman, K. Yokoyama, M. H. Gelb, . L. Croft-s et al., Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity, Bioorg. Med. Chem. Lett, vol.11, pp.761-764, 2001.

. M. O'neill-p, . A. Ward-s, . G. Berry-n, J. P. Jeyadevan, G. A. Biagini et al., A medicinal chemistry perspective on 4-aminoquinoline antimalarial drugs, Curr. Top. Med. Chem, vol.6, pp.479-507, 2006.

. Oyakhirome-s, S. Issifou, P. Pongratz, F. Barondi, . Ramhar-ter-m et al., Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria, Antimicrob. Agents Chemother, vol.51, pp.1869-1871, 2007.

G. Padmanaban, . A. Nagaraj-v, and . Rangarajan-p.n, An alternative model for heme biosynthesis in the malarial parasite, Trends Biochem. Sci, vol.32, pp.443-449, 2007.

H. Sakamoto, S. Thiberge, S. Akerman, C. J. Janse, . G. Carvalho-t et al., Towards systematic identification of Plasmodium essential genes by transposon shuttle mutagenesis, Nucleic Acids Res, p.174, 2005.

. Sato-s, . Clough-b, . Coates-l, and . J. Wilson-r, Enzymes for heme biosynthesis are found in both the mitochondrion and plastid of the malaria parasite Plasmodium falciparum, Protist, vol.155, pp.117-125, 2004.

. Sato-s and . J. Wilson-r, The plastid of Plasmodium spp.: a target for inhibitors, Curr. Top. Microbiol. Immunol, vol.295, pp.251-273, 2005.

. H. Schirmer-r, B. Coulibaly, . Stich-a, M. Scheiwein, H. Merkle et al.,

&. Kouyate-b, Methylene blue as an antimalarial agent, Redox Rep, vol.8, pp.272-275, 2003.

. Singh-n, G. Cheve, . A. Avery-m, and . R. Mccurdy-c, Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme, Curr. Pharm. Des, vol.13, pp.1161-1177, 2007.

. Surolia-n and . Padmanaban-g, de novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite, Biochem. Biophys. Res. Commun, vol.187, pp.744-750, 1992.

. &. Surolia-n and . Surolia-a, Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum, Nat. Med, vol.7, pp.167-173, 2001.

. C. Uhlemann-a, . Cameron-a, . Eckstein-ludwig-u, J. Fischbarg, P. Iserovich et al., A single amino acid residue can determine the sensitivity of SERCAs to artemisinins, Nat. Struct. Mol. Biol, vol.12, pp.628-629, 2005.

W. C. Van-voorhis, . L. Rivas-k, P. Bendale, L. Nallan, C. Horney et al., Pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase, vol.51, pp.3659-3671, 2007.

, NOVEL TARGETS FOR ANTIMALARIAL CHEMOTHERAPY, vol.225

E. X-th, , 2008.

, Parasite, vol.15, pp.219-225, 2008.

J. L. Vennerstrom, . Arbe-barnes-s, . Brun-r, . A. Charman-s, . C. Chiu-f et al.,

&. Charman and W. N. , Identification of an antimalarial synthetic trioxolane drug development candidate, Nature, vol.430, pp.900-904, 2004.

. F. Waller-r, . J. Keeling-p, . G. Donald-r, B. Striepen, E. Handman et al., Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum, Proc. Natl. Acad. Sci. USA, vol.95, pp.12352-12357, 1998.

. Wengelnik-k, . Vidal-v, M. L. Ancelin, . M. Cathiard-a, J. L. Morgat et al., A class of potent antimalarials and their specific accumulation in infected erythrocytes, Science, vol.295, pp.1311-1314, 2002.

W. J. Jomaa-h, Isoprenoid biosynthesis of the apicoplast as drug target, Curr. Drug Targets, vol.8, pp.3-13, 2007.

J. Wiesner, K. Kettler, J. Sakowski, . Ortmann-r, . M. Katzin-a et al., Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo, Angew. Chem. Int. Ed. Engl, vol.43, pp.251-254, 2004.

. J. Woodrow-c and . Krishna-s, Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance, Cell. Mol. Life Sci, vol.63, pp.1586-1596, 2006.